FDA+ roundup: Agency re­struc­tures chief sci­en­tist's of­fice; First vote on Rob Califf as com­mis­sion­er pushed to next week

The FDA this week an­nounced fur­ther changes to re­vamp its struc­ture, this time with al­ter­ations to its Of­fice of the Chief Sci­en­tist that were agreed to by HHS late last month.

The FDA’s OCS has de­cid­ed to shift its tech­nol­o­gy trans­fer pro­gram from the Of­fice of Reg­u­la­to­ry Sci­ence and In­no­va­tion to the OCS Im­me­di­ate Of­fice to fur­ther en­hance the ef­fec­tive­ness of the agency’s out­side part­ner­ship pro­grams.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.